Literature DB >> 17279740

Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.

F Anthony Romero1, Wu Du, Inkyu Hwang, Thomas J Rayl, F Scott Kimball, Donmienne Leung, Heather S Hoover, Richard L Apodaca, J Guy Breitenbucher, Benjamin F Cravatt, Dale L Boger.   

Abstract

A study of the structure-activity relationships (SAR) of 2f (OL-135), a potent inhibitor of fatty acid amide hydrolase (FAAH), is detailed, targeting the 5-position of the oxazole. Examination of a series of substituted benzene derivatives (12-14) revealed that the optimal position for substitution was the meta-position with selected members approaching or exceeding the potency of 2f. Concurrent with these studies, the effect of substitution on the pyridine ring of 2f was also examined. A series of small, nonaromatic C5-substituents was also explored and revealed that the K(i) follows a well-defined correlation with the Hammett sigma(p) constant (rho = 3.01, R2 = 0.91) in which electron-withdrawing substituents enhance potency, leading to inhibitors with K(i)s as low as 400 pM (20n). Proteomic-wide screening of the inhibitors revealed that most are exquisitely selective for FAAH over all other mammalian proteases, reversing the 100-fold preference of 20a (C5 substituent = H) for the enzyme TGH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279740      PMCID: PMC2531193          DOI: 10.1021/jm0611509

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  72 in total

1.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

2.  Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist.

Authors:  S R Fernando; R G Pertwee
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

3.  Anandamide may mediate sleep induction.

Authors:  R Mechoulam; E Fride; L Hanus; T Sheskin; T Bisogno; V Di Marzo; M Bayewitch; Z Vogel
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

Review 4.  Cannabinoid receptors and their endogenous agonist, anandamide.

Authors:  J Axelrod; C C Felder
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.

Authors:  D G Deutsch; R Omeir; G Arreaza; D Salehani; G D Prestwich; Z Huang; A Howlett
Journal:  Biochem Pharmacol       Date:  1997-02-07       Impact factor: 5.858

6.  Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.

Authors:  D L Boger; J E Patterson; Q Jin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  Molecular characterization of human and mouse fatty acid amide hydrolases.

Authors:  D K Giang; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.

Authors:  D G Deutsch; S Lin; W A Hill; K L Morse; D Salehani; G Arreaza; R L Omeir; A Makriyannis
Journal:  Biochem Biophys Res Commun       Date:  1997-02-03       Impact factor: 3.575

9.  Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.

Authors:  L De Petrocellis; D Melck; N Ueda; S Maurelli; Y Kurahashi; S Yamamoto; G Marino; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1997-02-03       Impact factor: 3.575

10.  The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells.

Authors:  X Guan; B F Cravatt; G R Ehring; J E Hall; D L Boger; R A Lerner; N B Gilula
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  29 in total

Review 1.  Interferometric methods for label-free molecular interaction studies.

Authors:  Amanda Kussrow; Carolyn S Enders; Darryl J Bornhop
Journal:  Anal Chem       Date:  2011-11-07       Impact factor: 6.986

2.  Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Authors:  Jessica K DeMartino; Joie Garfunkle; Dustin G Hochstatter; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

Review 3.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 4.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

5.  Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders.

Authors:  Kay Ahn; Douglas S Johnson; Benjamin F Cravatt
Journal:  Expert Opin Drug Discov       Date:  2009-07       Impact factor: 6.098

6.  Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Authors:  John M Keith; William M Jones; Mark Tichenor; Jing Liu; Mark Seierstad; James A Palmer; Michael Webb; Mark Karbarz; Brian P Scott; Sandy J Wilson; Lin Luo; Michelle L Wennerholm; Leon Chang; Michele Rizzolio; Raymond Rynberg; Sandra R Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2015-11-02       Impact factor: 4.345

7.  A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

Authors:  Victoria Magrioti; George Naxakis; Dimitra Hadjipavlou-Litina; Alexandros Makriyannis; George Kokotos
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

8.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

9.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  Discovery libraries targeting the major enzyme classes: the serine hydrolases.

Authors:  Katerina Otrubova; Venkat Srinivasan; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.